INTRODUCTION
Chromatin remodeling pathways have significant but complex roles in cancer progression. Both histone hypoacetylation and hyperacetylation are associated with various cancer subtypes. Histone deacetylases (HDACs) are commonly recruited by coactivators and co-repressors to provide crucial points of pathway control in both normal and cancerous tissues. 1 Consequently, considerable effort has been placed on finding small molecule inhibitors that regulate HDAC function in vivo. 2 Recently, two studies have shown that loss of global chromatin regulators mH2A and L(3)MBT promote melanoma progression and brain tumors, respectively, 3, 4 demonstrating that cancer progression can be driven by loss of genes that have a broad effect on the cellular transcription profile. This view is amplified in recent work on retinoblastoma, in which epigenetic changes are central to disease progression. 5 Nevertheless, deregulation of chromatin remodeling activity and its global effect on modulation of various pathways that lead to disease progression in whole animal cancer models remain poorly understood.
In mammals, Sin3 proteins can recruit HDACs to chromatinbound transcription factors to repress expression of target genes. 6, 7 Sin3A regulates processes important for development and homeostasis including mitochondrial biogenesis, cell death and neuronal fate selection. [8] [9] [10] In addition, Sin3A is an obligate partner of Mad (Mxi1)-class nuclear factors and is required for Mad-mediated repression of Myc-dependent transcription. 11, 12 Sin3B has some overlapping functional properties with Sin3A that include regulating E2F/Rb and Myc-dependent gene transcription. 13 Whole animal mouse models found that knockouts for both sin3A and sin3B led to different degrees of early embryonic lethality and differential targeting of muscle precursors. 8, 13 Sin3A is an important negative regulator of several cancerrelated factors including p53, Rb and E2F in addition to Myc. [14] [15] [16] Members of the Sin3 complex have also been linked to tumorigenesis, most notably BMRS1. [17] [18] [19] However, the complex roles of chromatin-related factors in cancer are mirrored by recent Sin3 studies. For example, downregulation of Sin3A is associated with progression of non-small cell lung cancer but, conversely, reduced viability of metastatic MDA-MB-231 and MCF7 breast cancer cell lines. 20 A clear mechanistic understanding has yet to emerge of how Sin3 proteins contribute to tumorigenesis in situ.
Dominant activating mutations in the receptor tyrosine kinase (RTK) Ret lead to Multiple Endocrine Neoplasia Type 2 (MEN2), a cancer syndrome characterized by Medullary Thyroid Carcinoma (MTC)-an overgrowth of parafollicular C cells-and potentially other tumors including pheochromocytoma and parathyroid adenomas. We recently established a Drosophila MEN2 model 21 in which Drosophila Ret (dRet) was engineered to contain analogous MEN2-type mutations; these dRet MEN2 isoforms were then targeted to the emerging eye epithelium. Our genetic studies indicated that dRet MEN2 activates multiple signaling pathways previously implicated in tumorigenesis including Ras, Src and JNK; these pathways are also active in the presence of mammalian oncogenic Ret isoforms.
Mutations in the sin3a locus-encoding the sole Drosophila Sin3 ortholog-proved to be especially strong genetic modifiers of dRet MEN2 activity, indicating a strong functional link between the two loci. 21 Here, we demonstrate that Drosophila Sin3a regulates important aspects of tumorigenesis including altered polarity, destabilized adherens junctions, activation of metastasis markers and epithelial-to-mesenchymal transition (EMT). We find that Sin3a potently modulates dRet MEN2 -, Src-and JNK-dependent invasion by regulating a specific module of genes that include both known and novel Sin3 targets. Interestingly, the majority of these novel targets are normally activated-not repressed-by Sin3a, suggesting it can act in an HDAC-independent manner. We further establish that Sin3 proteins can regulate similar sets of cell invasion genes in human thyroid and lung cancer cell lines, and show that reducing Sin3 levels enhance their invasive potential. This view is supported by our analysis of patient lung tumor samples and ONCOMINE data indicating that Sin3 mRNA is significantly downregulated in a variety of cancers. Through a variety of approaches, our studies establish for the first time a role for Sin3 proteins in regulating an important and specific aspect of tumorigenesis: invasion/metastasis.
RESULTS

Sin3a loss enhanced oncogenic dRet and led to metastasis-like behavior
To better understand the function of Sin3A, we explored an in-vivo model of tumorigenesis. Removal of one genomic copy of the sin3a locus significantly enhanced the 'rough eye phenotype' of targeted dRet MEN2B (gmr4dRet MEN2B ; sin3a þ / À ), leading to a smaller eye with a greater disruption of the ommatidial array; this indicates that Sin3a normally functions to counter oncogenic dRet MEN2B activity (Figures 1a-c) . 21 Recently, we developed an invasion/migration assay in which transgenes are targeted to a discrete region of the developing wing epithelium using a driver based on the patched (ptc) promoter. 23 Targeting oncogenic Ret to this region (ptc4Ret MEN2B ) showed mild overgrowth and minimal migration of cells from the ptc domain (Figure 1f ). Additional RNA interference-mediated knockdown of sin3a (ptc4sin3a RNAi ; dRet MEN2B ) led to strong enhancement: large numbers of cells shifted basally below the epithelium and migrated significant distances from the ptc domain (Figure 1g ). These data indicate that reducing Sin3a significantly increases the invasive capacity of cells transformed by dRet MEN2B . Remarkably, reducing sin3a alone (ptc4sin3a RNAi ) was sufficient to direct mild but consistent cell migration as targeted cells released basally (Figure 1h) . A stronger knockdown led to more aggressive cell invasion as many migrating cells traveled a significant distance before eventually undergoing apoptosis (Figure 1i ; Supplementary Figures S1A and B) . Blocking apoptotic cell death with the Caspase inhibitor P35 also enhanced the sin3a
RNAi migration phenotype ( Supplementary Figures S1C and D) . Similarly, targeted sin3a reduction led to a rough eye phenotype, often with growths emerging from the eye (Figure 1d ; gmr4 sin3a
RNAi Ret MEN2B , Supplementary Figures 1G-I) ; addition of the Caspase inhibitor Diap1 led to enhanced overgrowth and secondary tumors that grew stably at distant sites in approximately one-third of the adults examined. Figure 1j shows an example of secondary tumors due to migration to the adult legs. dCsk 23 and sin3a are therefore the only two Drosophila loci reported to direct invasive migration when their activity alone is reduced.
Recent reports have proposed that mammalian Sin3A acts as an oncogene or as a tumor suppressor. For example, Sin3A was found to promote ERa-positive breast cancer cell survival 24 or act in opposition to the Myc oncogene. 11, 25 Sin3a acted in opposition to Myc in our assays: expressing Drosophila Myc in the context of dCsk RNAi (not shown) or sin3a RNAi (Figure 1l ) led to strong enhancement of tissue overgrowth. These data are again consistent with Sin3a acting as a tumor suppressor in our assays.
Reducing sin3a promoted EMT and invasive migration Invasive behavior of transformed cells is commonly associated with destabilization of adherens junctions, loss of cell polarity and increased motility of cells, collectively referred to as EMT. Markers of EMT include the mesenchymal fate marker N-Cadherin. 26 , 27 We observed cell-autonomous N-Cadherin expression in a subset of ptc4sin3a RNAi p35 cells within the wing pouch region; expression was most often modest but was substantial in some discrete groups (Figures 1m and n) RNAi cells were frequently found 'burrowing' through basal regions where the ECM was degraded (Figure 2k ). These data indicate that Sin3a normally acts to oppose EMT.
Sin3a acts primarily as a positive regulator of genes involved in cell invasion/migration To identify Sin3a genomic targets that, when deregulated, are candidates to promote invasion/migration, we performed a genome-wide ChIP-seq analysis. We generated and validated an antibody to the N-terminus of Drosophila Sin3a (Supplementary Figure S2D ; Negre et al. 28 ). ChIP-seq analysis of 0-16 h embryo extracts identified B100 genes that met our threshold and reproducibility criteria ( Supplementary Figures S4 and S5 ; Materials and methods).
A striking number of Sin3a targets that emerged from our analysis are closely linked to tumorigenesis (Figure 3a) . Utilizing RT-PCR we confirmed 41/44 targets as altered in vivo in sin3a RNAi larval extracts. Of note, orthologs of several genes previously shown to be Sin3a targets-for example, MCM5, Rbf, p53 and MMS19 8 -were indeed bound (ChIP-seq) and regulated (RT-PCR) by Drosophila Sin3a (Figure 3a) . ChIP-seq analysis placed Sin3a at the promoter regions of practically all of its targets; additional low-level ChIP-seq signals extended into the adjacent transcribed regions (Figure 5f ) as has been reported for mammalian Sin3 proteins. 29 To our surprise, our ChIP-seq and RT-PCR data indicated that Sin3a acts predominantly as an activator: while 33% (11/33) of its targets were reduced in the presence of sin3a
RNAi , 73% (24/33) were reduced with the stronger dicer;sin3a
RNAi knockdown (Figure 3a) , consistent with recent mammalian data. 29 To monitor the status of active chromatin more directly, we explored the change in histone modification patterns upon sin3a knockdown. Acetylation of lysine residues on histones (for example, H3K9Ac, H4K12Ac and H4K5Ac) promotes active transcription through loosening and unfolding of local chromatin structure. 30 Methylation is primarily associated with transcriptional silencing but methylation of some histones, like H3K4Me3, promote active transcription through inhibition of repressive nucleosome remodeling and histone-deacetylase complexes. 31 Indeed, knockdown of sin3a led to in-vivo loss of active chromatin markers H3K4Me3 and H4K12Ac in the wing disc and H3K9Ac in the salivary glands (Figures 3b, c and 4p ). Reducing Sin3a in the wing disc did not alter other markers of active chromatin including H3K22Me3 and H4K5Ac. In contrast to the salivary gland, H3K9Ac signal was increased in sin3a
RNAi wing epithelia (Figure 5g ), indicating that Sin3a's role as a transcription factor is complex and context dependent.
Sin3a opposes Src pathway activity Western analysis of wing discs epithelia with mild and strong sin3a knockdowns confirmed that the Sin3a pathways identified through ChIP-seq were indeed deregulated. These include effectors of the Src, Jnk, pathways as well as regulators of actin dynamics (Figure 4p (e-i, k-n) Invasion assays in the L3 wing disc using ptc4dicer2, eGFP. All images are composite overlays of Z-stacks spanning the full depth of the epithelia; in this and subsequent figures cells are visualized with uas-eGFP and the apical surface is visualized as part of a whole mounted tissue. Yellow brackets in (e), (h) and (i) demarcate the patched (ptc) domain; white bracket indicates region of migrating cells at base of wing disc. Expression of oncogenic Ret, ptc4dRet MEN2B (f ) leads to some proliferation but little invasion compared with control (e). Additional knockdown of sin3a, ptc4sin3a
RNAi dRet MEN2B (g) leads to significantly enhanced cell invasion into adjacent wild-type (WT) tissue (non-GFP). (h, i) sin3a knockdown is sufficient to induce invasion into adjacent WT tissue. (j) Co-expression of Caspase inhibitor Diap1 and sin3a knockdown transgenes in the developing eye (gmr4sin3a RNAi diap1 GFP) led to migration to distant sites including adult legs (arrows). (k, l) Expression of Drosophila Myc leads to overproliferation and some invasion (k) which is considerably enhanced when sin3a is simultaneously knocked down, ptc4sin3a
RNAi dMyc B (l). (m, n) Co-expression of apoptosis inhibitor p35 in sin3a knockdown cells, ptc4sin3a
RNAi p35, led to expression of EMT marker N-Cadherin in individual cells (m) or in groups of cells (n).
'module'. To test this concept, we examined several of these factors to determine whether they mediated Sin3's regulation of invasion in both flies and mammals.
Our ChIP-seq and RT-PCR data indicated that Drosophila C-terminal Src-kinase (dCsk) is a transcriptional target of the Sin3a complex ( Figure 3a ). Csk-class proteins actively suppress Src activity by directly phosphorylating residues within Src's C-terminus. 32 The Src pathway is an important mediator of tumorigenesis including oncogenic Ret signaling, 21, 33, 34 and we further explored the relationship between Csk/Src and Sin3a.
Reducing sin3a activity broadly within the wing disc led to both reduced dCsk mRNA expression and increased levels of active Src (pSrc; Figures 4p and 5g). It also led to a strong, synergistic enhancement of dCsk RNAi as assessed by increased migration of cells in the wing (Figure 4e ) and enhanced overgrowth and progressive tissue degeneration in the eye (Figure 4b ; Supplementary Figure S2E ). Lethality of hypomorphic dCsk alleles 35 was enhanced by removing a genomic copy of sin3a (Supplementary Figure S2F) . In contrast, knockdown of dCsk in the wing did not affect Sin3a protein levels (Supplementary Figures  S3A-C) .
Together, these data indicate that Sin3a normally acts to oppose Src pathway activity, at least in part through regulation of dCsk. Reduced Sin3a activity leads to increased Src function.
Jnk and E-cadherin signaling regulates sin3a-dependent invasion The Jnk pathway is commonly mis-regulated in human tumors. It has been linked to both mouse and Drosophila models of Retinduced tumorigenesis 21, 36 and to MMP1 expression in flies. 37 Our ChIP-seq data indicated that the Sin3a complex regulated the Jnk pathway components Atf-2 and MKK4, which were downregulated upon sin3a knockdown (Figure 3a ). MKK4 is a metastasis suppressor that is frequently lost in a number of human cancer cell lines and in a large breast tumor subgroup. [38] [39] [40] Previous Drosophila studies indicated that MKK4 opposed Jnk pathway activity in a complex interaction with MKK7 (Hep) and MAPKKK (TAK1), demonstrating the careful balance of signals required for Jnk pathway activity. 41 Indeed, activated phospho-Jnk (pJnk) levels were elevated in a dose-dependent manner when sin3a was reduced (Figures 4p and 5g ), indicating that reduction of MKK4 may contribute to Jnk activation.
Removing one genomic copy of the Drosophila jnk ortholog bsk or its target jun significantly suppressed the EMT and invasion resulting from reduced sin3a in the wing; expressing a dominantnegative form of bsk also led to near complete loss of cell migration (Figures 4f-h ). Interestingly, expression of bsk DN in the context of sin3a
RNAi dCsk RNAi led to massive overgrowth and increased MMP1 expression but invasive migration was still absent (Figure 4i ), pointing to multiple, complex interactions between Sin3a, Src and Jnk. Conversely, sin3a
RNAi -induced invasion was enhanced by removing a genomic copy of the dual specificity Jnk phosphatase puckered (puc), a negative regulator of Jnk signaling ( Figure 4k ). We conclude that Sin3a regulates Ret-mediated invasion/migration in part through its regulation of Jnk pathway components.
Our previous work indicated that reducing E-Cadherin suppressed dCsk-mediated cell migration, 23 suggesting that E-Cadherin normally provides a signal to promote dCskdependent invasion. Recent studies in B-raf-driven mouse cancer models and human tumor analysis have suggested that highly metastatic cells may have elevated levels of E-Cadherin to aid metastatic spread.
42 sin3a RNAi -mediated migration displayed a similar requirement for E-Cadherin: ectopic E-Cadherin expression in mild sin3a
RNAi cells led to increased invasion as assessed by greater distances traveled from the ptc expression domain, while removal of a genomic copy of E-Cadherin suppressed sin3a
RNAi-strong -driven invasion (Figures 4l and m) . By contrast, removal of a genomic copy of polychaetoid-a component of the adherens junction that provides structural support-did not affect sin3a
RNAi -driven invasion (Figure 4o ). Our western analysis showed RT-PCR analysis of putative sin3a targets identified by ChIP-seq. Expression of putative sin3a targets in sin3a RNAi (blue columns) and dicer, sin3a RNAi (red columns) was normalized with respect to expression in control w À embryos. Error bars represent standard error. The majority of targets examined showed lower expression when sin3a was knocked down, suggesting that sin3a is acting as an activator on these loci. (b) H3K4Me3 staining in ptc4sin3a
RNAi experiments, note significantly lower signal in tissue (green, asterisk) where sin3a is reduced. (c) H3K9Ac staining in salivary gland 'FLP-out' clones generated by heat shocking act4CD24GAL4; hsFLP,eGFP;sin3a
RNAi dicer2 larvae and analyzing cells containing eGFP-positive clones. Note significantly lower signal in tissue (green) where sin3a is reduced. 
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RNAi-stromg pJnk pSrc E-Cad RNAi and (d) sin3a RNA individually induced low-level invasion, simultaneous knockdown of both (e) dCsk RNAi , sin3a RNA led to synergistic enhancement of invasion. (f-g') Enhanced invasion by strong sin3a knockdown, ptc4sin3a
RNAi-strong ( Figure 1i ) was suppressed by removing a genomic copy of bsk (f ) or jun (g). Mmp1 signal was still visible in discs with incomplete suppression of invasion by jun (g'). (h, h') Enhanced invasion was also suppressed by co-expression of bsk DN (h); anti-Caspase staining (h') indicated apoptosis in cells that were not invading. (i-j') Mmp1 expression in ptc4sin3a
RNAi dCsk RNAi (i,i') and ptc4sin3a RNAi dCsk RNAi bsk DN (j, j') discs. bsk DN suppressed the synergistic invasion induced by sin3a/dCsk double knockdown. In ptc4sin3a
RNAi dCsk RNAi bsk DN cells, Mmp1 expression was still induced (j') and considerable proliferation was observed (j), suggesting a non-linear effect of Jnk pathway inhibition in this triple combination. (k) Removal of a genomic copy of the Jnk-phosphatase puc (k) led to enhanced invasion compared with sin3a knockdown alone (Figure 1h ). (l) Overexpression of E-cad, ptc4sin3a
RNAi Ecad, increased migration. (m) Removal of a genomic copy of E-Cadherin, ptc4sin3a RNAi-strong Ecad À / þ , reduced migration. (n, o) Removal of a genomic copy of polychaetoid, ptc4sin3a
RNAi-strong pyd
Western detection of indicated proteins from indicated genotypes; tubulin was used as loading control. sin3a knockdown resulted in increased pJnk, pSrc and reduced E-Cadherin and Sin3a levels; H4K12Ac levels, indicative of actively transcribed chromatin, also decreased slightly. Stronger sin3a knockdown led to intermediate E-Cadherin levels. Relative pixel density for each marker as measured by ImageJ software is shown in red.
that, compared with control, mild sin3a
RNAi cells had the lowest levels of E-Cadherin whereas more invasive sin3a
RNAi-strong cells had intermediate levels (Figure 4p) . Combined with our genetic data, this suggested that although reduced E-Cadherin is linked to invasion (Figures 2e and 4p) , optimal invasion may require some E-Cadherin. Finally, as neither E-Cadherin nor Dlg promoters were bound strongly by Sin3a in our ChIP-seq analysis, deregulation of these junctional components likely occurs indirectly through downstream Sin3a targets.
Sin3a regulates actin remodeling factors Based on our ChIP-seq data, one of the largest classes of Sin3a targets are regulators of cell migration. These include Rho1, Rac1, Arf51F and members of the RhoGAP and RhoGEF families (Figure 3a) . The Rho superfamily of small GTPases regulates cell migration by altering Actin cytoskeletal dynamics, and has been implicated in progression of various cancers. 43 Figure 3a) ; the resulting synergy should increase Rho1 activity and alter cell motility. Other regulators of Actin remodeling including pSrc, pJnk, and Rho1 levels were also significantly elevated (Figures 4p  and 5g) .
We observed similar changes in the presence of dRet MEN2B for nearly all targets we examined. Activation of Ret-alone or in the presence of sin3a knockdown-led to activated pSrc, pJnk and pErk as well as increased Rho1 expression (Figure 5g ). These effects were enhanced in some targets by further knocking down Sin3a, while other targets that were already strongly activated were unaffected by further reduction of Sin3a (Figure 5g ). An important exception was E-Cadherin. Although sin3a knockdown led to lower levels of E-Cadherin (Figures 2e and 4p) , simultaneous activation of Ret led to intermediate levels of E-Cadherin (Figure 5g ). Taken together, these findings suggest that careful titration of E-Cadherin levels might be required for aggressive invasion/migration (Figures 1g and i) .
Our data emphasize the importance of Sin3a in targeting regulators of signal transduction and cell motility, two important aspects of transformation and invasion. They also point to the remarkable consistency by which loss of Sin3a upregulates activators and downregulates inhibitors to achieve these ends. Sin3a regulates Wg signaling by both opposing TCF and controlling b-Catenin stability In the process of scoring sin3a phenotypes in the wing we noted that a region flanking the dorso-ventral (D/V) boundary showed especially strong cell migration and Caspase activation (Figure 5a ). The Drosophila Wnt ortholog Wg is expressed by a single row of cells at the D/V boundary 44 and we postulated that a Wgdependent signal was affecting invasion/migration of flanking sin3a knockdown cells. Indeed, expression of a dominant-negative isoform of the Wg effector TCF fully suppressed invasion by sin3a
RNAi cells (ptc4sin3a RNAi TCF DN ; Figure 5b ). Drosophila TCF can act either as an activator or as a repressor depending on its association with the b-Catenin ortholog Armadillo; the in-vivo consensus binding site AGAWAW (W ¼ A/T) has been established for TCF. 45 We identified a subset of Sin3a target genes that contained consensus TCF-binding sites within 5 kb of their transcriptional start sites. For example, and relevant to the data presented above, 6 sites were identified for Mkk4, 22 for RhoGAP93B and 31 for dCsk (Figure 5c ), whereas chance would predict a single site within the 5-kb region. This suggested that TCF might oppose transcriptional regulation of a subset of Sin3a targets. We addressed this directly by a western analysis of the Sin3a targets identified through ChIP-seq and RT-PCR. While knockdown of Sin3a led to increased Src, Jnk and Rho1 activities, simultaneous expression of TCF DN strongly suppressed their activation (Figure 5g ). Global histone modification changes induced by sin3a knockdown were also reversed by simultaneous expression of TCF DN , indicating that Sin3a and TCF functionally oppose each other on chromatin at a global level (Figures 5d, e  and g ). Other signaling pathways including PI3K (pAKT) were suppressed by TCF DN but were unaffected by sin3a RNAi alone (Figure 5g ), indicating that TCF has roles beyond its interactions with Sin3a.
Knockdown of sin3a led to reduced levels of the b-Catenin ortholog Armadillo (Arm) at the adherens junctions (Figure 2c ) yet, surprisingly, led to an overall increase in Arm protein levels within wing discs (Figure 5g ). Activated dRet MEN2 also induced increased Arm levels, similar to a recent report regarding human MEN2 cancer cells. 46 This shift of Arm away from the junctions is reminiscent of a similar phenomenon described in human tumors, [47] [48] [49] though the mechanism by which b-Catenin is altered is not well understood.
We explored the possibility that Sin3a increases cytoplasmic Arm stability by targeting a component of the Arm/b-Catenin degradation complex. The complex is composed of Axin, glycogen synthase kinase 3b (GSK3b), Casein Kinase 1 and Adenomatous polyposis coli (Apc): together they promote phosphorylation and degradation of b-Catenin. Protein Phosphatase 1b (PP1b) counters the activity of the degradation complex by dephosphorylating Axin, which leads to reduced phosphorylation and increased stabilization of b-Catenin. 50 In our ChIP-seq analysis, Sin3a bound strongly to the promoter of PP1-87B (dPP1b), the Drosophila ortholog of PP1b ( Figure 5f ); as a control we found that Sin3a bound to MCM5, a known target of mammalian Sin3A. 8, 51 Indeed, knockdown of sin3a-or expression of dRet MEN2B -led to increased dPP1b levels; as anticipated, phosphorylation of the upstream degradation complex component GSK3b was unaffected (Figure 5g) . Apc is also a target of Sin3a and knockdown of sin3a led to increased levels of Apc mRNA ( Figure 3a) ; however, our findings indicate that, at least in the Drosophila wing disc, increased dPP1b levels have a dominant effect over increased Apc levels, allowing for increased levels of b-Catenin.
We conclude that reduction of Sin3a upregulates PP1, in turn stabilizing and therefore increasing levels of Arm protein. These results indicate a novel functional and molecular link between Sin3a and the Wg-Arm/b-Catenin axis. It supports the view that a key role for Sin3 proteins is to oppose activation of Wnt pathway signaling, adding PP1b as a component of the 'invasion module' regulated by the Sin3 complex.
Reduced Sin3 in human cancers
Overall, our studies demonstrate that activation of Drosophila dRet MEN2B or reduction of Sin3a leads to activation of a 'tumor module'-including Src, Jnk, Rho1 and Arm/b-Catenin pathwaysthat in turn promotes cell motility and invasion. We next asked if a similar process is conserved in human cancers. Mutations in sin3 loci have not been reported for human tumors and we hypothesized that, similar to flies, partial reduction of Sin3 mRNA levels would be optimal to promote cancer progression. Of note, a recent report associated reduced sin3a expression with greater likelihood of non-small cell lung cancer tumors but did not detect significant loss of heterozygosity (LOH) at the sin3a locus. 52 Analyzing patient tumor microarray data from the ONCOMINE database, we found that Sin3 mRNA levels were consistently and significantly reduced in most tumor types we examined RNAi TCF DN showed equivalent H3K9Ac signal in clones and wild-type (WT) cells. Compare with Figure 4b . (e) Analysis of histone modification markers in three contexts: salivary gland FLP-out clones, expression of UAS constructs throughout the whole wing disc (765-GAL4) and expression of UAS constructs within the ptc domain (ptc-GAL4). The loss of many markers of active chromatin by sin3a
RNAi was restored by co-expressing TCF DN showing that Sin3a and TCF oppose each other globally on chromatin. (f ) Strong Sin3a ChIP-seq signal at the transcriptional start region of Drosophila PP1-87B, the ortholog of vertebrate PP1b. Strong signal in the upstream region of MCM5, a previously described target of Sin3a. Image generated by Integrated Genome Browser 6.5.3 software (Integrated Genome Browser, UNC, Charlotte, NC, USA). (g) Western detection of indicated proteins from indicated genotypes; syntaxin was used as loading control. sin3a knockdown resulted in increased pJnk, pSrc, Rho1, dPP1a and Arm/b-Catenin. Co-expression of TCF DN suppressed all markers that were elevated upon sin3a knockdown.
Drosophila Sin3a mediates tumorigenesis TK Das et al including lung, kidney, liver, gastric and breast tumors, as well as in lymphoma (Figure 6a ). We analyzed 12 patient lung tumor samples and found a median fourfold reduction of sin3A/B mRNA levels compared with non-diseased lung tissue (Figure 6b; Supplementary Figure S6A ). In addition, we found that Sin3a targets established through our fly studies-Csk, Rho and PP1b-were regulated in an analogous manner in the human tumor cohorts from ONCOMINE (Figure 6a ; Supplementary Figure 8A ) as well as in the 12 patient lung tumor samples (Figure 6b ). For example, in these tumor cohorts Csk mRNA was downregulated while PP1b and RhoA were upregulated.
C-jun gene is a known transcriptional target of the b-Catenin axis:
53 both in the Oncomine collection and in our patient tumor samples C-jun mRNA was significantly increased in tumor cohorts with reduced Sin3 mRNA levels. b-Catenin mRNA levels were not significantly altered in our patient tumor samples, indicating that changes in b-Catenin activity are not due to alterations in its own transcription (Supplementary Figure 8C) . These data further suggest that Sin3 proteins act as suppressors of an 'invasion module' in both flies and human tumors. We next tested this model in transformed and normal human cell lines. Figure  S9 ), mirroring our Drosophila results. Our ONCOMINE and lung tumor data suggested that Sin3 proteins may act in tumors other than MTCs (Figures 6a and b;  Supplementary Figures S6 and S8) . We provided functional data to support this view by examining a human A549 lung adenocarcinoma cell line with siRNAs that showed consistent knockdown of Sin3A or Sin3B (Supplementary Figures S6B, S7C and S7D and data not shown). siRNA-mediated Sin3A, Sin3B or Sin3A þ B knockdown within A549 cells resulted in elevation of pSRC, pJNK, RhoA, b-Catenin and PP1b levels (Figure 6d; Supplementary Figure S9 ).
Finally, we tested if Sin3 proteins controlled the same module of genes in non-transformed cells. siRNA knockdown of Sin3 proteins in HEK293 human embryonic kidney cells showed robust upregulation of pSRC, pJNK, RhoA, b-Catenin and PP1b levels, indicating that Sin3 proteins can regulate expression of these genes during normal cellular function (Figure 6e ; Supplementary Figure S9 ).
Importantly, milder siRNA mediated knockdowns (20 nM) consistently activated Sin3 targets more potently than stronger knockdowns (40 nM; Figures 6c-e; Supplementary Figure S9 ). This is consistent with previous reports that full Sin3A/B knockouts exhibit significant cell lethality. 8, 13 The stronger effects of mild Sin3 reduction may explain why human tumors exhibited reduced levels of Sin3 mRNA but not complete loss (Figures 6a and b) .
Reducing Sin3 levels increased invasiveness of human lung adenocarcinoma cells Together, our Drosophila studies indicate that Sin3a is a tumor suppressor that regulates key pathways involved in proliferation, EMT and invasion/migration. Similar to in-vivo tumors cultured MZ-CRC-1 cells are only slowly migratory (not shown), and we therefore focused on A549 human lung adenocarcinoma cells. 54 Overexpression of human Sin3A and/or Sin3B (Supplementary Figures S7A and B) reduced cell number up to B40% (Figure 7a ), indicating that Sin3 proteins can oppose tumor cell expansion. We next assessed Sin3's role in migration of transformed mammalian cells using a wound healing 'scratch' assay. Importantly, siRNAmediated knockdown of Sin3A increased cell motility/invasiveness of A549 cells almost twofold compared with control (Figures 7b  and d) . That is, moderate reduction of Sin3A did not make cells unhealthy but instead increased their motility and potential for invasion. FACS analysis indicated a modest shift of these cells into S phase, indicating that excess proliferation is unlikely to account for the rapid wound healing (Supplementary Figure S6C) .
These data are consistent with the view that Sin3 proteins normally act as negative regulators of tumor progression including migration in both lung adenocarcinoma and MEN2 thyroid cells. Our data demonstrate a marked parallel between Sin3-regulated pathways in Drosophila and vertebrates, controlling cell motility and invasion during cell transformation.
DISCUSSION
Despite growing interest, the precise in-vivo role of Sin3 proteins in tumorigenesis remains poorly defined. Our Drosophila studies define specific in-vivo target pathways and demonstrate that Sin3a promotes tumorigenesis including cell motility and invasion. Pathways include Src, Jnk, Rho-GTPases and Wnt/b-Catenin/TCF, defining a 'module of cell invasion' (Figure 7e ). The result is emergence of invasive migration, the first step in metastasis. Our genetic studies further predicted that partial Sin3 complex reduction would strongly enhance other oncogenes. Consistent with this view, our studies in human tumors and tumor cells have confirmed that (i) Sin3 expression is commonly reduced in a broad palate of tumor types and (ii) reduction of Sin3 deregulates many of the pathways defined in our Drosophila studies as involved in cell motility and invasion. (iii) Many of these Sin3a targets are also regulated in a similar manner in the human tumors, further supporting our hypothesis that Sin3 proteins regulate a genetic 'module of invasion'.
Novel insights into sin3a-mediated invasive migration pathways ChIP-seq and RT-PCR analyses validated our genetic evidence that Sin3a is a significant regulator of invasion/cell migration and EMT. Several genes are particularly noteworthy. Direct targeting of dCsk by the Sin3a complex confirmed the strong synergy observed between sin3a and dCsk mutants in vivo, and is consistent with our previous work demonstrating that dCsk/Src signaling is a primary regulator of cell migration. 23 Similarly, identification of Rho and Rho-GTPases as targets of Sin3a is also consistent with its role in normally opposing migration. The ability of TCF DN to suppress Sin3a-mediated (i) transcriptional regulation, (ii) invasion and (iii) histone modification suggests a globally antagonistic relationship between TCF and Sin3a.
Our studies also establish a novel link between Sin3 and b-Catenin activity. We provide evidence that Sin3 proteins control the stability of b-Catenin protein by transcriptionally regulating PP1b, an important component of the b-Catenin degradation complex. b-Catenin protein levels are sensitive to even slight changes in phosphorylation of components of the degradation complex including Axin and GSK3b. 50 Increased b-Catenin levels, for example, through mutations in APC gene in colorectal tumors, result in translocation to the nucleus where it can direct various pro-invasive programs of gene expression. 49, 55, 56 Reduction of Sin3 function represents a novel mechanism by which increased levels of nuclear b-Catenin emerge to promote tumor progression in the absence of mutations in degradation complex components such as APC.
In addition to controlling b-Catenin stability, Sin3a and Wnt signaling interact at a second level: many Sin3a target promoters also had TCF-binding sites. How these two interact at target sites is unclear. Emerging evidence in both flies and vertebrates indicates that not only is TCF converted to an activator by b-Catenin but, conversely, TCF/b-Catenin can act as a repressor complex (reviewed in Cadigan 57 ). Add to this the ability of reduced Sin3a to increase nuclear b-Catenin, and the potential for complexity including feedback loops is substantial. These possibilities will need to be examined on a target by target basis.
Sin3a acts primarily as a transcriptional activator More than 70% of Sin3a 0 s targets were under positive regulation; we also observed significant in-vivo loss of active chromatin markers H3K4Me3, H3K9Ac and H4K12Ac in cells where Sin3a levels were reduced. Previous studies have provided circumstantial evidence that Sin3A functions as an activator independent of HDACs: knockdown of HDAC and sin3A had opposite effects on H3 and H4 acetylation; 51 gene expression profiles of HDAC and sin3A knockdown showed only limited overlap; 58 and Sin3A positively regulated a large number of its targets. 29 Perhaps these contextdependent differences in Sin3 activity reflect regulated access to multiple transcriptional complexes. 29 Implications for cancer Sin3 proteins control diverse transcriptional networks that likely make it unfeasible for tumor cells to completely lose sin3 function. Indeed, null sin3a clones failed to thrive in vertebrates or Drosophila S2 cells, 8, 51 a major reason for our focus on knockdown approaches. Indeed, milder knockdowns of Sin3 components in cancer cells resulted in more potent activation of Src, Jnk, Rho and b-Catenin pathways. Further, our RT-PCR analysis and a survey of a wide variety of human tumors showed consistent but partial downregulation of Sin3 mRNA.
Oncogene and tumor suppressor function have traditionally been analyzed in the context of a few targets/pathways. Our in-vivo analysis of Sin3 protein function suggests that the overall 'network effect' of tumor suppressors may underlie their ability to regulate tumorigenesis. Moderate regulation of multiple targets relevant for invasion/migration, as we show for Sin3a, might be an effective mechanism to promote tumorigenesis without disrupting, for example, cell viability.
Our studies further link Sin3 as a central modulator of Ret MEN2 disease progression. MEN2 tumors typically require years to exhibit metastatic disease, 59 providing an opportunity for secondary loci to participate in advancement to metastasis. Significant to this point, in our invasion studies expression of dRet MEN2B alone directed proliferation but was unable to induce invasion; the (e) A model for metastatic invasion at tumor boundaries. Sin3a regulates diverse signaling pathways including Src, Jnk and Actin remodeling factors including Rho and Rac. Through PP1, Sin3a also regulates b-Catenin levels. We propose that these genes act as a Sin3 'invasion module' that can strongly enhance other oncogenes. Activation of these pathways leads to invasion; Sin3a normally acts to restrain cells from invasive signals.
addition of sin3a knockdown was required to develop an aggressive metastasis-like phenotype. This highlights the potential for a sin3a-regulated 'invasion module' that promotes and enhances tumor progression as an adjunct to primary oncogenic mutations. Such 'invasion modules' might be a fairly common mechanism underlying tumor progression.
MATERIALS AND METHODS
Analysis of cell-cycle distribution
After the cells were transfected, they were stained with propidium iodide to ascertain the DNA content and determine cell-cycle distribution within the cell population as previously described. 60 ChIP-Seq
Rabbit polyclonal Sin3a antibody for Chip-seq and immunohistochemistry: we fused N-terminal amino acids 500-620 of Drosophila Sin3a to Glutathione S-Transferase. Fusion protein was expressed, purified, and rabbits were immunized (ProteinTech Group Inc., Manchester, UK). ChIPseq experiments have been performed on 0-16 h developing Drosophila embryos as previously described. 28 Two replicate experiments and one reference sample (Input chromatin) were run on three different lanes of Illumina Genome Analyzer II (Illumina Genome Analyzer, San Diego, CA, USA) (1 Â 36 bp). Sequences obtained were mapped on the DM3 reference genome with bowtie and signal files and peaks were generated using MACS with a 1% false discovery rate setting. The reproducibility of 4083 transcription factor-binding sites was 0.87 (recommended 0.8 per modENCODE; 53, 54 good signal-to-noise ratio of 114.77 (median signal-to-noise ratio for modENCODE projects is 132.22; min 33; max 540). Raw data are accessible in GEO with the following accession number: GSE23122.
Fly stocks, genetics and subcloning Fly stocks were obtained from Bloomington and VDRC (Vienna Drosophila RNAi Center) Drosophila stock centers, R Carthew, M Mlodzik, M Vidal and E Bangi. UAS-sin3a
RNAi flies obtained from VDRC were mobilized by crossing to flies expressing transposase (D2-3 Sb; TM6B). A 1-h heat shock of hs-FLPase was used to generate FLP-out clones of RNAi transgenes in 0-48 h old animals. UAS-Ret MEN2B flies were generated by ligating a partial EcoR1-digested GMR-dRet MEN2B DNA fragment 21 into EcoR1 site of pUAST vector. Transgenic flies were generated by standard protocol.
Histology and antibodies
Third instar salivary glands and wing discs were staged and fixed in 4% paraformaldehyde. Immunofluorescence was performed as described. 61 Antibodies used were Cleaved Caspase3, pRet, pJnk, pAkt, pGSK3b, p-C-jun (Cell Signaling, Danvers, MA, USA), anti-pSrc(Y 418 ) (Invitrogen, Grand Island, NY, USA), anti-Laminin (Abcam, Cambridge, MA, USA), anti-pERK (Sigma, St Louis, MO, USA), plus anti-Actin, anti-Arm, anti-Dlg, anti-E-Cadherin, antiMmp, anti-Rho1, anti-Syntaxin (Developmental Studies Hybridoma Bank). Anti-Sin3A, anti-Sin3B, anti-Actin, anti-GAPDH, anti-PP1a and anti-RhoA antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and anti-b-Catenin antibody (from BD Biosciences, San Jose, CA, USA). All histone modification antibodies were obtained from ActiveMotif (Carlsbad, CA, USA).
ONCOMINE data
Primary sources for the tumor data for the different cancers from ONCOMINE were the following: lung, 62 lymphoma, 63 liver, 64 breast, 65 kidney, 66 and gastric. Quantitative real-time PCR and RT-PCR RNA was isolated from cell lines and patient tumors using the RNeasy Mini Kit (Qiagen). For each PCR, 1 mg RNA was reverse transcribed using iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA, USA). Each cDNA sample was subjected to PCR amplification with the SYBR green PCR Master Mix (Applied Biosystems Inc., Carlsbad, CA, USA) on an ABI PRISM 7900HT plate-reader instrument (Applied Biosystems Inc). All values were normalized to glyceraldehyde-3-phosphate dehydrogenase levels and compared with both 18S and Actin expression and additional controls.
For RT-PCR analysis of putative Sin3a targets, cDNA was made using RNA extracts from w-, sin3a
RNAi and Dicer; sin3a RNAi embryos. RT-PCR with gene-specific primers was performed using standard procedures. PCR products were run on 2% agarose gels and band pixel intensity was analyzed using Quantity One (Bio-Rad) Image analysis software. Experiments were performed at least three independent times and expression of each target in sin3a knockdown conditions was normalized with respect to expression in w-samples.
Western analysis
Ten third-instar discs of each genotype were dissolved in Lysis Buffer (50 mM Tris, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA) supplemented with protease inhibitor cocktail (Sigma) and phosphatase inhibitor cocktail (Sigma). For human cell lines, lysis was performed with RIPA buffer. Total protein in each sample was quantitated using BIORAD protein assay. Samples were boiled, resolved on SDS-PAGE and transferred by standard protocols. Membranes were stripped with SIGMA Restore stripping buffer and reprobed with other antibodies to assess signal under exactly the same loading conditions.
Wound healing assay A549 cells were transiently transfected with siRNAs when they were fully confluent. Twenty-four hours later media was changed and a single scratch per well was inflicted with a 1-ml pipette tip. Phase-contrast images were taken every 6-8 h at fixed landmarks (3 per well) in every well until wound was almost closed in knockdown experiments. Rate of wound closing was measured as the difference between original wound width minus final width divided by the hours elapsed (D o À D F )/hours. Three measurements per image were taken giving 9 (3 Â 3) data points per time point per treatment and the mean of these measurements was represented graphically.
